Information regarding the total number of voting rights and total number of shares of the Company as of May 30, 2025
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
Date | Total number of shares | Total number of voting rights |
| 05/30/2025 | 136,973,697 | Total gross of voting rights: 136,973,697 |
Total net* of voting rights: 136,738,528 |
* Net total = total number of voting rights attached to shares – shares without voting rights
| Last Trade: | US$16.43 |
| Daily Change: | 1.43 9.53 |
| Daily Volume: | 238,949 |
| Market Cap: | US$449.390M |
October 06, 2025 July 22, 2025 | |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
